Five Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib (APC) Trial

The Adenoma Prevention with Celecoxib (APC) Trial examined the efficacy and safety of the Cox-2 inhibitor, celecoxib, for sporadic colorectal adenoma prevention in patients at high risk for colorectal cancer (CRC). The trial randomized 2035 subjects to receive either placebo, celecoxib 200mg twice d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bertagnolli, Monica M., Eagle, Craig J., Zauber, Ann G., Redston, Mark, Breazna, Aurora, Kim, KyungMann, Tang, Jie, Rosenstein, Rebecca B., Umar, Asad, Bagheri, Donya, Collins, Neal T., Burn, John, Chung, Daniel C., Dewar, Thomas, Foley, T. Raymond, Hoffman, Neville, Macrae, Finlay, Pruitt, Ronald E., Saltzman, John R., Salzberg, Bruce, Sylwestrowicz, Thomas, Hawk, Ernest T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976587/
https://ncbi.nlm.nih.gov/pubmed/19336730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados